Trial Profile
Study on Prevention and Treatment of virus hepatitis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2012
Price :
$35
*
At a glance
- Drugs Peginterferon alfa-2a (Primary) ; Ribavirin (Primary) ; Interferon alpha-2b
- Indications Hepatitis C
- Focus Therapeutic Use
- 21 May 2012 Planned End Date changed from 1 Dec 2011 to 31 Dec 2012 as reported by Chinese Clinical Trial Register.
- 06 Dec 2010 New trial record